Naltrexone And Bupropion
A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients
Orexigen Therapeutics, Inc · Phase 1/2 · Not yet recruiting · Enrollment 64
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.